Targeted Medical Pharma Signs Agreement to Assign Certain Accounts Receivables to Cambridge Medical Funding Group

Los Angeles, November 27, 2012Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and sells prescription medical foods to physicians and pharmacies for the treatment of chronic disease, today reported the completion of an agreement under which certain accounts receivables will be assigned to New Jersey-based Cambridge Medical Funding Group, LLC (CMFG).

Under the terms of the agreement, medical providers who purchase products from Targeted Medical Pharma will have the option to assign certain accounts receivables from California Workers’ Compensation benefit claims to CMFG at a discounted rate.

“This agreement permits Targeted Medical Pharma to more quickly collect outstanding amounts owed to the company by physicians who will purchase our products, providing us with more opportunities to accelerate growth because of the improved time-to-collection,” said William Shell, M.D., CEO of Targeted Medical Pharma. “Physicians also will benefit from the reduced time spent on the billing and collection process and avoid lengthy delays in workers’ compensation payer reimbursements.”

About Cambridge Medical Funding Group, LLC

Based in Glen Rock, New Jersey, Cambridge Medical Funding Group provides specialized finance solutions to hospitals, surgical centers and medical providers, purchasing receivables and providing guaranteed upfront payments to these providers.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a specialty pharmaceutical company that develops and sells prescription medical foods to physicians and pharmacies for the treatment of chronic disease, including pain syndromes, obesity, sleep and cognitive disorders. The company manufactures nine proprietary prescription-only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are currently sold in the United States, Japan, and the Middle East. Targeted Medical Pharma also provides billing and collection services on behalf of dispensing physicians.

Forward Looking Statement

This press release about an agreement with Medical Funding Group, LLC may contain forward-looking statements related to Targeted Medical Pharma’s business strategy, outlook, objectives, plans, intentions or goals. The words “may,” “will,” “should,” “plans,” “explores,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Actual results could differ materially. Targeted Medical Pharma expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.

# # #

Targeted Medical Pharma Presents at the California Association of Healthcare Facilities’ Annual Convention

Los Angeles, November 14, 2012 — David Silver, M.D., executive vice president of scientific and medical affairs at Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), discussed the utilization of prescription only medical foods in a skilled nursing setting at this year’s California Association of Health Facilities’ 62nd annual convention, held  in Palm Springs, Calif., on November 12.

The presentation, “Safer and More Effective Pharmacologic Alternatives,” focused on the safety and efficacy of prescription medical foods for the long term management of pain, cognitive and sleep disorders.  Dr. Silver also presented initial data outcomes from an ongoing clinical trial among nursing home patients administered with the medical foods Sentra AM® and Sentra PM®.  Preliminary results among trial participants show an improvement in alertness, memory recall, balance, quality of sleep, sleep latency, sleep duration, as well as a reduction in nighttime awakenings.

“Medical foods provide physicians with a non-addictive and effective prescription alternative to the traditional pharmacologic treatments currently utilized in the skilled nursing setting,” said board certified rheumatologist Dr. Silver. “These medications offer patients a safer way to manage pain, sleep and cognitive disorders, without the risks associated with many single molecule agents currently utilized in this setting.”

Dr. Silver’s presentation can be downloaded by clicking here or visiting http://www.slideshare.net/TMEDPHARMA.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, and pharmacies for the treatment of chronic disease including pain syndromes, obesity, sleep and cognitive disorders.  The company manufactures nine proprietary prescription only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical.  These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.  Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are currently sold in the United States and Japan.  Targeted Medical Pharma also provides billing and collection services on behalf of dispensing physicians.

Forward Looking Statement

This press release regarding Dr. David Silver’s presentation, “Safer and More Effective Pharmacologic Alternatives,” and initial data results from an ongoing clinical trial among nursing home patients administered with the medical foods Sentra AM® and Sentra PM®,  may contain forward-looking statements related to Targeted Medical Pharma’s business strategy, outlook, objectives, plans, intentions or goals. The words “may,” “will,” “should,” “plans,” “explores,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Actual results could differ materially. Targted Medical Pharma expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.

# # #

Theramine® Featured on Lifetime Television Network’s “The Balancing Act”

Los Angeles, Nov. 13, 2012 – Lifetime Network’s “The Balancing Act,” recently featured the prescription-only medical food Theramine, an effective medication for reducing inflammation and pain associated with chronic pain syndromes.

During the segment, William Shell, M.D., Chief Executive Officer and Chief Scientific Officer of Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), discussed the benefits of Theramine for the dietary management of syndromes such as fibromyalgia and back pain.

Theramine is a prescription-only medical food regulated by the FDA and specially formulated to meet the increased nutritional requirements of pain syndromes. It is the subject of two large double-blind, randomized, multi-center trials and what we believe is a safe and effective option for treating pain syndromes without harmful side effects.

“The Balancing Act” is a one-hour morning show for women focusing on various topics including health, family and self-empowerment. The segment featuring Dr. Shell discussing Theramine will be rebroadcast on the network Monday, Dec. 10. Viewers can access the segment by visiting (http://www.tmedpharma.com/media/the-balancing-act-v1.php).

About Physician Therapeutics and Targeted Medical Pharma, Inc

Physician Therapeutics is a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of chronic disease including  pain syndromes, obesity, and sleep and cognitive disorders. The company manufactures nine proprietary medical food products, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are currently sold in the United States and Japan. Targeted Medical Pharma also provides billing and collection services on behalf of dispensing physicians.

# # #

Targeted Medical Pharma to Present at Upcoming Investor Conferences

Los Angeles, November 5, 2012 – Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the following investor conferences:

  • Wednesday, November 7, 2012
    14th Annual SoCal Bio Conference & Exhibition

    Omni Hotel – 251 South Olive Street, Los Angeles, CA
    2:00 p.m. Eastern Time (11:00 a.m. Pacific Time)
  • Thursday, November 29, 2012
    New York Society of Security Analysts’ (NYSSA) 16th Annual Investing in Life Sciences Conference

    NYSSA Conference Facilities – 1540 Broadway, New York, NY
    1:30 p.m. Eastern Time (10:30 a.m. Pacific Time)

A live webcast of the NYSSA presentation will be available at the company’s website at www.tmedpharma.com.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of chronic disease including pain syndromes, obesity, sleep and cognitive disorders. The company manufactures nine proprietary prescription only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are currently sold in the United States and Japan. Targeted Medical Pharma also provides billing and collection services on behalf of dispensing physicians.

Click here to download press release.